Prospective comparison of outcomes with azacitidine and decitabine in patients with AML ineligible for intensive chemotherapy

Zeidan, A.M. ✉; Fenaux, P.; Gobbi, M.; Mayer, J.; Roboz, G.J.; Krauter, J.; Robak, T.; Kantarjian, H.M.; Novák, J.; Jedrzejczak, W.W.; Thomas, X.; Ojeda-Uribe, M.; Miyazaki, Y.; Min, Y.H.; Yeh, S.-P.; Brandwein, J.M.; Gercheva, L.; Demeter, J. [Demeter, Judit (Hematológia), author] Department of Internal Medicine and Oncology (SU / FM / C); Griffiths, E.A.; Yee, K.W.L.; Issa, J.-P.J.; Bewersdorf, J.P.; Keer, H.; Hao, Y.; Azab, M.; Döhner, H.

English Comment, Correction (Journal Article) Scientific
Published: BLOOD 0006-4971 1528-0020 140 (3) pp. 285-289 2022
    Identifiers
    Subjects:
    • Haematology
    Citation styles: IEEEACMAPAChicagoHarvardCSLCopyPrint
    2025-04-02 02:25